SarZ is a key regulator of biofilm formation and virulence in Staphylococcus epidermidis.

The Journal of Infectious Diseases
Li WangQian Gao

Abstract

Biofilm-associated infection due to Staphylococcus epidermidis, the leading nosocomial pathogen, is a major problem for the public health system, but the regulation of this important phenotype is not completely understood. Using a highly discriminatory screening procedure for genes that influence biofilm formation, we identified the transcriptional regulator SarZ as a novel important determinant of biofilm formation and biofilm-associated infection, on the basis of the significant impact of sarZ on the transcription of the biosynthetic operon for biofilm exopolysaccharide. In addition, sarZ influenced the expression of a series of virulence genes, including genes that influence the expression of lipases and proteases, resistance to an important human antimicrobial peptide, and hemolysis. Our study indicates that the SarZ regulator has a key role in maintaining the typical S. epidermidis phenotype, which is characterized by pronounced biofilm formation and immune evasion, a likely reason for the success of S. epidermidis as a colonizing organism and pathogen in chronic, biofilm-associated infection.

References

Sep 1, 1985·Journal of Clinical Microbiology·G A Hébert, G A Hancock
Jun 1, 1997·FEMS Microbiology Letters·R Brückner
May 29, 1998·Infection and Immunity·M NilssonB Guss
May 29, 1998·Infection and Immunity·U FluckigerA L Cheung
May 23, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·I RaadK Rolston
Feb 13, 1999·Molecular Microbiology·Y ChienA L Cheung
May 21, 1999·Science·J W CostertonE P Greenberg
Apr 27, 2000·Journal of Bacteriology·P Watnick, R Kolter
Nov 9, 2000·The Journal of Infectious Diseases·C VuongM Otto
Nov 22, 2000·The Journal of Biological Chemistry·J HarderJ M Schroder
Jul 21, 2001·Lancet·P S Stewart, J W Costerton
Apr 5, 2002·Microbes and Infection·Cuong Vuong, Michael Otto
Jul 23, 2002·Frontiers in Bioscience : a Journal and Virtual Library·Ambrose L Cheung, Gongyi Zhang
Nov 1, 2002·The Lancet Infectious Diseases·Christof von EiffChristine Heilmann
Nov 19, 2002·FEMS Microbiology Letters·Kevin M ConlonJames P O'Gara
Jan 4, 2003·Journal of Bacteriology·B Saïd-SalimB N Kreiswirth
Jan 24, 2003·Infection and Immunity·Jagath L KadurugamuwaPamela R Contag
May 20, 2003·Molecular Microbiology·Jaione ValleIñigo Lasa
Aug 23, 2003·The Journal of Infectious Diseases·Cuong VuongMichael Otto
Feb 10, 2004·Frontiers in Bioscience : a Journal and Virtual Library·Michael Otto
Apr 23, 2004·Infection and Immunity·Anna RennermalmJan-Ingmar Flock
Aug 12, 2004·Proceedings of the National Academy of Sciences of the United States of America·Taeok BaeDominique M Missiakas
Jan 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jesse S WrightRichard P Novick
Mar 19, 2005·Journal of Bacteriology·María Angeles TormoJosé R Penadés
Feb 21, 2006·International Journal of Medical Microbiology : IJMM·Kok-Fai KongMichael Otto
Sep 7, 2006·Analytical and Bioanalytical Chemistry·Dietrich MackJohannes K-M Knobloch
Nov 8, 2006·Molecular Microbiology·Chikara KaitoKazuhisa Sekimizu
May 8, 2007·Applied and Environmental Microbiology·Shiming WangShunpeng Li
May 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Min LiMichael Otto

❮ Previous
Next ❯

Citations

Jun 5, 2010·Future Microbiology·Paul D Fey, Michael E Olson
Jun 15, 2013·International Journal of Environmental Research and Public Health·Feng Zhou, Yuyan Wang
Oct 31, 2015·Future Microbiology·Sharon KleinschmidtLouise M Hafner
Nov 28, 2012·Microbial Pathogenesis·Andrea L Lucas, Adhar C Manna
Jun 10, 2010·FEMS Immunology and Medical Microbiology·Maria PihlGunnel Svensäter
Apr 21, 2010·FEMS Immunology and Medical Microbiology·Chongzhen WangQian Gao
Oct 4, 2014·Clinical Microbiology Reviews·Karsten BeckerGeorg Peters
Apr 11, 2018·Environmental Microbiology·Yue ZhengMichael Otto
Aug 4, 2018·Antioxidants & Redox Signaling·Emma SevillaMaría F Fillat
May 5, 2017·Frontiers in Cellular and Infection Microbiology·Tianming LiMin Li
Nov 27, 2020·Computational and Structural Biotechnology Journal·Hoai T T NguyenMichael Otto
May 14, 2021·Archives of Microbiology·Marion AubourgJean-Christophe Giard
Aug 18, 2018·Microbiology Spectrum·Michael Otto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.